Theme: The competition focuses on hot topics and cutting-edge fields in ophthalmology, including but not limited to research proposals or achievements with innovativeness and clinical potential in the following areas: artificial intelligence (AI) in ophthalmology, gene therapy, stem cell therapy, in

Rooted in the Guangdong-Hong Kong-Macao Greater Bay Area with a global perspective, Zhongshan Ophthalmic Center (ZOC) at Sun Yat-sen University has championed global eye health with an open stance over the past six decades. During its 60th anniversary week, the center actively established platforms

Ophthalmologists from the Zhongshan Ophthalmic Center of Sun Yat-sen University reached a milestone on Sunday by successfully conducting the world's first remote robotic subretinal injection surgery. The surgery's core platform was an independently developed domestic 5G ophthalmic surgical robot. T

Research Summary   Ethical governance of artificial intelligence is a core issue for ensuring the healthy development of the technology. With the deep integration of medical AI in areas such as disease diagnosis and treatment planning, the ethical challenges it raises—including data privacy, algor

Cerebral visual impairment (CVI), also known as cortical visual impairment or neurological visual impairment, refers to a group of syndromes involving visual dysfunction caused by damage to the central visual pathways. Patients with CVI often show no organic lesions in routine eye examinations. Some

To fulfill our "patient-centered" goal and further improve medical services, Zhongshan Ophthalmic Center (ZOC) has launched the "Walking in Patients' Shoes" Clinical Service Experience Day. Administrative staff went to the clinical frontlines, observing from the patient's perspective, building deep

On September 27, 2025, Zhongshan Ophthalmic Center (ZOC) of Sun Yat-sen University, the Hainan Provincial Health Commission, and the Hainan Boao Lecheng International Medical Tourism Pilot Zone Administration signed a framework agreement in Lecheng, Hainan, to jointly establish the "Hainan Internati

Retinitis pigmentosa (RP) is a group of common, refractory blinding diseases characterized by progressive degeneration and death of photoreceptors and the retinal pigment epithelium (RPE). The causative genes and pathogenesis have not been fully elucidated. RPE cells are the crucial "support unit"

"To address the needs of early-stage cataract patients, we developed the world's first eye drops that can reverse cataracts," said Lin Haotian, Director of Zhongshan Ophthalmic Center (ZOC) at Sun Yat-sen University. The breakthrough was announced at a press conference on Guangdong's new quality pr

On September 21, 1982, supported by the Chinese government and upon the invitation of Professors Chen Yaozhen and Mao Wenshu from the Eye Hospital affiliated with Zhongshan Medical College (now Zhongshan Ophthalmic Center, SYSU), the world's first Flying Eye hospital, organized by ORBIS Internationa